Black Friday Code: DIGEST35

Can You Use LDN for Constipation Relief?

Using low-dose naltrexone (LDN) for chronic pain, depression, and inflammatory conditions is very popular right now.

But what about constipation—can LDN help with this, too? The quick answer is no, as LDN isn’t a laxative, nor does it have any properties that help people poop. 

That said, if your constipation is a symptom of an underlying gastrointestinal issue, especially an inflammatory disorder, LDN might be a helpful therapy.

Let’s dig into this nuance to see if LDN might be worth a try for constipation. If not, I’ll give you better ways to increase bowel movements.

What is LDN Used For?

Used at full dosage (at least 50 mg daily), naltrexone is an opioid antagonist that can be prescribed as a treatment for opioid (opiate) use disorder and alcohol use disorder 1

However, when given at a much lower dose (as low-dose naltrexone, or LDN), the medication has different effects, such as reducing pain and inflammation 2.

Low-dose naltrexone therapy has been around since the 1980s, when an AIDS doctor began using 1.5 to 3 milligrams of naltrexone as an off-label drug to improve AIDS treatment.

Since then, LDN has become a popular go-to for many in alternative medicine, but the drug lacks the rigorous study of large-scale clinical trials, so a lot of its use is not evidence-based 1.

That said, LDN falls under the category of safe and affordable ($20–30/month 3) for many who may want to try it for pain or inflammatory conditions. For example, the LDN Research Trust says popular uses of LDN include treating cancers, autoimmune diseases, chronic pain, and mental health issues 4.

LDN and Pain

While there aren’t large or high-quality LDN studies for any disease or health condition, pain relief is the potential LDN benefit with the most scientific backing. Studies have found:

  • LDN use is linked with reductions in chronic pain and uncontrollable muscle contractions in people with complex regional pain syndrome 5.
    • This type of chronic pain usually develops after an injury, surgery, stroke, or heart attack, and is excessively painful.
  • LDN may safely improve some symptoms for people with fibromyalgia (widespread muscle pain) 6.
  • LDN and amitriptyline (an antidepressant that can reduce nerve pain) may be equally good at helping patients with painful diabetic neuropathy, but LDN is far more tolerable than amitriptyline 7.

The standard of evidence is still quite weak in all these cases, and higher-quality research is necessary to confirm the findings.

Skin Conditions

Evidence also suggests that LDN may be helpful for some rare skin conditions, including severe itching, lichen planopilaris (which causes scarring of the scalp), and the rare genetic condition, Hailey-Hailey disease 8

Depression

One tiny but encouraging study found that LDN may help enhance the benefits of antidepressants in people with major depression 9

Inflammatory Bowel Disease (IBD)

Some data suggest that, compared to placebo, LDN for 8–12 weeks may safely improve symptoms and intestinal inflammation in people with active Crohn’s disease, a form of IBD 10. It’s worth noting that constipation can be a symptom of Crohn’s 11. Therefore, in someone with Crohn’s-related constipation, LDN could help relieve this symptom.

LDN and Constipation

If LDN can benefit general constipation, there’s no solid evidence for it. 

However, one naltrexone-offshoot called methylnaltrexone CAN help a specific form of constipation. This might be where people have gotten the misconceived idea that LDN relieves constipation.

Methylnaltrexone reduces constipation specifically related to opiate (opioid) use 12 13 14 15. Unlike LDN, methylnaltrexone can’t cross the blood-brain barrier, so it only acts on opioid receptors in places like the gut, and it has very different effects 16. Plus, methylnaltrexone is given at high doses (like 150 mg) compared to LDN (less than 5 mg), and it’s most effective when delivered under the skin. 

All this means is that LDN and methylnaltrexone should be considered very different medications. Unfortunately, the ample research showing that methylnaltrexone is a good treatment for opioid-induced constipation doesn’t extend to low-dose naltrexone.

LDN and Gut Conditions

To say that LDN doesn’t help constipation isn’t the whole picture. We can’t discount that some people swear by LDN for easing gut conditions that may include constipation as a symptom. 

Gut conditions that people use LDN for include:

Patient Experiences

It’s not in-depth or strong research, but one survey asking patients about the good and bad effects of the LDN they took for gastrointestinal conditions had some interesting findings on constipation 17.

The patients in the survey were from a single gastroenterologist’s practice and had been prescribed LDN for IBS (with or without SIBO), chronic constipation of unknown origin, or IBD.

Only 12 patients with chronic constipation completed the survey, but of these respondents:

  • 7 (~58%) reported a considerable improvement 
  • 1 (~8%) reported a moderate improvement
  • 3 (25%) reported a mild improvement
  • 1 (~8%) reported no change

For the other conditions, the results were mixed:

Of 12 patients with IBS but not SIBO, seven (58%) reported moderate or considerable improvements, two (17%) had no changes, and three (25%) reported feeling a lot worse. 

As for the 85 people with IBS and SIBO, about 47 (55%) reported moderate or considerable improvements, 11 (13%) said they had mild improvements, 23 (27%) had no changes, and four (5%) reported feeling moderately or considerably worse.

Finally, of the eight IBD patients, three (37%) reported moderate or considerable improvements, one (13%) said they had mild improvements, and four (50%) were unchanged. 

It’s worth noting that 74 (63%) of the 117 GI patients who took the survey had side effects while taking LDN—their complaints were mostly related to the nervous system and gut. However, plenty of other research has demonstrated a much lower rate of side effects. 

The side effect rate in this study may have been high because of its observational design. In other words, people need motivation to send back a mailed survey, so those with unusually good or bad experiences are more likely to respond. In contrast, people who had an average experience of LDN might not have been motivated to fill out and return the survey.

Circling back, the bottom line is that LDN therapy is not a proven treatment for constipation, but some people report that it works for them.

That said, it doesn’t make sense to try LDN without first trying diet and lifestyle steps that are proven to relieve constipation.

Proven Constipation Treatments

Before you reach for LDN, take a look at the following natural, science-based approaches I’ve found to relieve and prevent constipation.

Quick Relief

Several supplements that studies have found useful for quickly relieving constipation are psyllium fiber 18, magnesium 19, and senna (or aloe). For example,

  • Psyllium is a gluey, bulk-forming fiber that helps to regulate the bowels without producing excessive gas, making it particularly useful for people with IBS 18.
  • Magnesium—specifically magnesium citrate or hydroxide (Milk of Magnesia)—is an effective osmotic laxative, which means it draws water into the bowel and softens the poop, making it easier to pass 19
  • Senna is a tropical herb shown in a randomized clinical trial to reduce constipation in 69% of patients 19. Aloe can be an effective alternative to senna.

See the following table for science-based dosing information.

ldn and constipation

Prevention

Diet Changes

Getting relief from constipation involves making changes both to foods in the diet as well as when and how they’re eaten.

  • For healthier, more frequent bowel movements, a healthy, balanced diet is key. I advise my constipated clients to eat 20:
    • Mainly whole foods 
    • Plenty of dietary fiber (fruits, vegetables, and whole grains, taking into account any fiber sources you may not tolerate well)
    • Watery foods (like soups and vegetables)
    • Fewer sweets, dressings, and spicy, greasy, or processed foods
    • Fewer of any foods they associate with constipation (for example, some people may notice cheese or eggs can be problematic)
  • We also work on improving their eating habits to ease their constipation, I recommend that my clients 20:
    • Eat only when hungry, start with smaller portions, eat slowly, and stop when they feel full.
    • Don’t lie down after eating or eat close to bedtime.
    • Don’t use a straw for beverages (introduces air into the digestive tract, which can contribute to constipation).
    • Eat without distractions.
    • Don’t do intense exercise right after eating.
    • Keep a food diary to try to identify what foods make constipation worse. 

Probiotics

Probiotics can play a crucial role in preventing constipation long term. Extensive research indicates that probiotics can improve stool frequency, consistency, and motility (the movement of food through the digestive system) 21 22 23. Additionally, probiotics can help alleviate bloating that comes with constipation 23 24.

Research suggests that when it comes to relieving constipation and other gut conditions, multistrain probiotics may be more effective than single-strain probiotics. For example, one meta-analysis found that multistrain probiotics were especially good at softening stools and increasing the number of times people moved their bowels. They were also good for reducing bloating 23.

This reflects our experience at the clinic, where we routinely find that a three-pronged approach to probiotic therapy has the best results. The three probiotics we use are:

Exercise and Hydration

It makes sense that getting regular moderate exercise can help prevent constipation. Moving around on two feet helps the normal contractions of the digestive tract and helps gravity pull gut contents downward. Consistently doing aerobic exercises, like jogging or a pump class (fast-paced, repetitive strength training), seems to work best to diminish constipation 25.

When exercising, it’s important to stay hydrated, especially in hot weather. Drinking plenty of fluids helps prevent constipation because it ensures the fiber in the digestive tract is soft and easy to pass 20.

Make Time for Yourself

These supports for the gut-brain connection may also help prevent constipation:

  • Spending time outdoors 26 27 28 
  • Practicing mindfulness 29 and yoga 30
  • Gut-focused cognitive behavioral therapy 31

If constipation continues despite trying all the above self-help measures, it’s time to see your health care professional or a gastroenterology specialist 20.

Still Want to Try LDN?

LDN isn’t FDA-approved, so If you’d still like to try it for constipation, you’ll need to find a LDN-focused health care professional who is willing to prescribe it to you from a compounding pharmacy. Compounding means altering a drug (in this case, full-strength naltrexone) to tailor it to your needs (in this case, for low-dose naltrexone). The LDN Research Trust may be able to help you find a prescriber.

When starting LDN, the usual protocol is to gradually increase the dose from 1 mg (or less, if you’re very sensitive) to up to 4.5 mg over 10–14 days.

In general, all doses of naltrexone appear to be safe and unlikely to cause serious negative side effects for up to 1 year 6 10 32. Longer-term data are lacking, though. 

The most common adverse effects appear to be mild abdominal pain, diarrhea, constipation, nausea, and vivid dreams 6

LDN and Constipation: Other Treatments First

There’s no evidence that LDN is useful for general constipation. Most people can successfully prevent constipation by eating a healthy high-fiber diet, taking probiotics, exercising, relieving stress, and drinking plenty of fluids. And for quick relief, excellent choices are psyllium, magnesium, and senna.

Nevertheless, if constipation is a consequence of inflammatory bowel disease, a prescribing clinician can help decide whether LDN could relieve it. But if constipation is related to opioid usage, a different naltrexone derivative called methylnaltrexone—not LDN—may be helpful (with a doctor’s assistance).

Chronic constipation is often just part of a bigger gut health picture. If you need help with anything on your journey toward better digestive health, we are here to help. I invite you to read my book, Healthy Gut, Healthy You, or reach out to our clinic for a consultation.

The Ruscio Institute has developed a range of high-quality formulations to help our clients and audience. If you’re interested in learning more about these products, please click here. Note that there are many other options available, and we encourage you to research which products may be right for you. The information on DrRuscio.com is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.

➕ References

  1. Toljan K, Vrooman B. Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization. Med Sci (Basel). 2018 Sep 21;6(4). DOI: 10.3390/medsci6040082. PMID: 30248938. PMCID: PMC6313374.
  2. Kim PS, Fishman MA. Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review. Curr Pain Headache Rep. 2020 Aug 26;24(10):64. DOI: 10.1007/s11916-020-00898-0. PMID: 32845365.
  3. How much does Low Dose Naltrexone (LDN) cost? | LDN Research Trust – The Low Dose Naltrexone Charity [Internet]. [cited 2024 Apr 4]. Available from: https://ldnresearchtrust.org/how-much-does-low-dose-naltrexone-ldn-cost
  4. What is Low Dose Naltrexone (LDN)? | LDN Research Trust – The Low Dose Naltrexone Charity [Internet]. [cited 2024 Apr 4]. Available from: https://ldnresearchtrust.org/what-is-low-dose-naltrexone-ldn
  5. Soin A, Soin Y, Dann T, Buenaventura R, Ferguson K, Atluri S, et al. Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review. Pain Physician. 2021 Jul;24(4):E393–406. PMID: 34213865.
  6. Aitcheson N, Lin Z, Tynan K. Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis. Aust J Gen Pract. 2023 Apr;52(4):189–95. DOI: 10.31128/AJGP-09-22-6564. PMID: 37021443.
  7. Srinivasan A, Dutta P, Bansal D, Chakrabarti A, Bhansali AK, Hota D. Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial. J Diabetes. 2021 Oct;13(10):770–8. DOI: 10.1111/1753-0407.13202. PMID: 34014028.
  8. Ekelem C, Juhasz M, Khera P, Mesinkovska NA. Utility of naltrexone treatment for chronic inflammatory dermatologic conditions: A systematic review. JAMA Dermatol. 2019 Feb 1;155(2):229–36. DOI: 10.1001/jamadermatol.2018.4093. PMID: 30484835.
  9. Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, et al. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants. J Affect Disord. 2017 Jan 15;208:6–14. DOI: 10.1016/j.jad.2016.08.029. PMID: 27736689.
  10. Parker CE, Nguyen TM, Segal D, MacDonald JK, Chande N. Low dose naltrexone for induction of remission in Crohn’s disease. Cochrane Database Syst Rev. 2018 Apr 1;4:CD010410. DOI: 10.1002/14651858.CD010410.pub3. PMID: 29607497. PMCID: PMC6494424.
  11. Signs and Symptoms of Crohn’s Disease | Crohn’s & Colitis Foundation [Internet]. [cited 2024 Jun 21]. Available from: https://www.crohnscolitisfoundation.org/patientsandcaregivers/what-is-crohns-disease/symptoms
  12. Vijayvargiya P, Camilleri M, Vijayvargiya P, Erwin P, Murad MH. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation. Aliment Pharmacol Ther. 2020 Jul;52(1):37–53. DOI: 10.1111/apt.15791. PMID: 32462777.
  13. Sridharan K, Sivaramakrishnan G. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials. J Pain Symptom Manage. 2018 Feb;55(2):468-479.e1. DOI: 10.1016/j.jpainsymman.2017.08.022. PMID: 28919541.
  14. Mehta N, O’Connell K, Giambrone GP, Baqai A, Diwan S. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Postgrad Med. 2016 Feb 23;128(3):282–9. DOI: 10.1080/00325481.2016.1149017. PMID: 26839023.
  15. Zhang Y-Y, Zhou R, Gu W-J. Efficacy and Safety of Methylnaltrexone for the Treatment of Opioid-Induced Constipation: A Meta-analysis of Randomized Controlled Trials. Pain Ther. 2021 Jun;10(1):165–79. DOI: 10.1007/s40122-021-00237-0. PMID: 33575953. PMCID: PMC8119523.
  16. Sizar O, Genova R, Gupta M. Opioid-Induced Constipation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. PMID: 29630236.
  17. Ploesser J, Weinstock LB, Thomas E. Low dose naltrexone: side effects and efficacy in gastrointestinal disorders. Int J Pharm Compd. 2010 Apr;14(2):171–3. PMID: 23965429.
  18. van der Schoot A, Drysdale C, Whelan K, Dimidi E. The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Clin Nutr. 2022 Oct 6;116(4):953–69. DOI: 10.1093/ajcn/nqac184. PMID: 35816465. PMCID: PMC9535527.
  19. Morishita D, Tomita T, Mori S, Kimura T, Oshima T, Fukui H, et al. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. Am J Gastroenterol. 2021 Jan 1;116(1):152–61. DOI: 10.14309/ajg.0000000000000942. PMID: 32969946.
  20. Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, Castro A, Cebrián-Cuenca A, de Torres-Sánchez A, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J Clin Med. 2022 Dec 24;12(1). DOI: 10.3390/jcm12010145. PMID: 36614945. PMCID: PMC9821052.
  21. Wen Y, Li J, Long Q, Yue C-C, He B, Tang X-G. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials. Int J Surg. 2020 Jul;79:111–9. DOI: 10.1016/j.ijsu.2020.04.063. PMID: 32387213.
  22. Miller LE, Ouwehand AC, Ibarra A. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta-analysis of randomized controlled trials. Ann Gastroenterol. 2017 Sep 21;30(6):629–39. DOI: 10.20524/aog.2017.0192. PMID: 29118557. PMCID: PMC5670282.
  23. Zhang C, Jiang J, Tian F, Zhao J, Zhang H, Zhai Q, et al. Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults. Clin Nutr. 2020 Oct;39(10):2960–9. DOI: 10.1016/j.clnu.2020.01.005. PMID: 32005532.
  24. Ford AC, Quigley EMM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014 Oct;109(10):1547–61; quiz 1546, 1562. DOI: 10.1038/ajg.2014.202. PMID: 25070051.
  25. Gao R, Tao Y, Zhou C, Li J, Wang X, Chen L, et al. Exercise therapy in patients with constipation: a systematic review and meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2019 Feb;54(2):169–77. DOI: 10.1080/00365521.2019.1568544. PMID: 30843436.
  26. Bray I, Reece R, Sinnett D, Martin F, Hayward R. Exploring the role of exposure to green and blue spaces in preventing anxiety and depression among young people aged 14-24 years living in urban settings: A systematic review and conceptual framework. Environ Res. 2022 Nov;214(Pt 4):114081. DOI: 10.1016/j.envres.2022.114081. PMID: 35973463.
  27. Shuda Q, Bougoulias ME, Kass R. Effect of nature exposure on perceived and physiologic stress: A systematic review. Complement Ther Med. 2020 Sep;53:102514. DOI: 10.1016/j.ctim.2020.102514. PMID: 33066853.
  28. Sudimac S, Sale V, Kühn S. How nature nurtures: Amygdala activity decreases as the result of a one-hour walk in nature. Mol Psychiatry. 2022 Nov;27(11):4446–52. DOI: 10.1038/s41380-022-01720-6. PMID: 36059042. PMCID: PMC9734043.
  29. Shah K, Ramos-Garcia M, Bhavsar J, Lehrer P. Mind-body treatments of irritable bowel syndrome symptoms: An updated meta-analysis. Behav Res Ther. 2020 May;128:103462. DOI: 10.1016/j.brat.2019.103462. PMID: 32229334.
  30. Shree Ganesh HR, Subramanya P, Rao M R, Udupa V. Role of yoga therapy in improving digestive health and quality of sleep in an elderly population: A randomized controlled trial. J Bodyw Mov Ther. 2021 Jul;27:692–7. DOI: 10.1016/j.jbmt.2021.04.012. PMID: 34391308.
  31. Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, et al. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology. 2018 Jul;155(1):47–57. DOI: 10.1053/j.gastro.2018.03.063. PMID: 29702118. PMCID: PMC6035059.
  32. Bolton M, Hodkinson A, Boda S, Mould A, Panagioti M, Rhodes S, et al. Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis. BMC Med. 2019 Jan 15;17(1):10. DOI: 10.1186/s12916-018-1242-0. PMID: 30642329. PMCID: PMC6332608.

Getting Started

Book your first visit

Discussion

I care about answering your questions and sharing my knowledge with you. Leave a comment or connect with me on social media asking any health question you may have and I just might incorporate it into our next listener questions podcast episode just for you!

Description Description